61 results
Pathophysiology Euglycemic DKA - Mechanism of SGLT-2 Inhibitors #Pathophys #Endocrine #Euglycemic #DKA #SGLT2 #Mechanism
Pathophysiology Euglycemic ... Pathophys #Endocrine #Euglycemic ... #DKA #SGLT2 #Mechanism
SGLT2 Inhibitors and Euglycemic DKA

Risk factors for euglycemic DKA in those on an SGLT2i include:
 •
SGLT2 Inhibitors ... and Euglycemic ... Risk factors for euglycemic ... is closed • SGLT2 ... #Euglycemic #DKA
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Ketoacidosis (EuDKA) SGLT2 ... @accpcardprn #Euglycemic
Metabolic Acidosis with Anion Gap - KILU Mnemonic

K - Ketoacidosis
	• DKA
		- With normal glucose, ask if
glucose, ask if on SGLT2 ... - Eugylcyemic ... ketoacidosis in SGLT2 ... inhibitors and SGLT2
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... Action: Inhibits SGLT2 ... candidiasis) • Euglycemic ... EricsMedicalLectures/featured #SGLT2
PocketPEM - Resus Meds
#Management #Pharm	#Peds #EM	#Resus #Medications #ResusMeds #Resuscitation #PocketCard #PocketPEM
PocketPEM - Resus Meds ... Management #Pharm #Peds ... #EM #Resus #Medications
Pathophysiology of Euglycemic DKA in SGLT2 Inhibitors
 • Kidney: Glycosuria, Natriuresis, ↑ Ketone bodies reabsorption
 •
Pathophysiology of Euglycemic ... DKA in SGLT2 Inhibitors ... Ketogenesis → Euglycemic ... @priti899 #Euglycemic
PocketPEM - Wound Closure Suture Guide #Management #Peds #EM #Wound #Closure #Suture #Selection #Removal #PocketCard #PocketPEM
Guide #Management #Peds ... #EM #Wound #Closure
PocketPEM - Airway - SOAPME #Management #Peds #EM #PICU #Airway #PocketCard #SOAPME #PocketCard #PocketPEM
SOAPME #Management #Peds ... #EM #PICU #Airway
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... mcclaffertyMD #SGLT2 ... #inhibitors #EBM